Iron Triangle Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-261,741
Closed -$15.1M 37
2024
Q3
$15.1M Buy
+261,741
New +$14.1M 2.09% 18
2024
Q1
Sell
-500,000
Closed -$24.9M 38
2023
Q4
$24.9M Buy
+500,000
New +$24.4M 3.22% 16
2023
Q2
Sell
-1,179,736
Closed -$64.2M 30
2023
Q1
$64.2M Buy
1,179,736
+529,736
+81% +$25.8M 9.26% 1
2022
Q4
$31.5M Sell
650,000
-250,000
-28% -$11M 5.64% 7
2022
Q3
$34.2M Buy
+900,000
New +$40.1M 5.98% 4
2020
Q1
Sell
-142,220
Closed -$7.14M 33
2019
Q4
$7.14M Buy
+142,220
New +$6.66M 1.89% 22

Other funds holding SNY

Iron Triangle Partners's SNY Position: Q4 2024 in Review

Iron Triangle Partners sold out of Sanofi (SNY) in Q4 2024, closing a stake of 261,741 shares — an estimated $15.1M sold.

Iron Triangle Partners first reported a position in SNY in Q4 2019 and held it in 6 quarters. The position peaked at $64.2M in Q1 2023. 730 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

  • Iron Triangle Partners reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
  • Iron Triangle Partners sold 261,741 Sanofi shares in Q4 2024, an estimated $15.1M.
  • Iron Triangle Partners first reported a position in Sanofi in Q4 2019 and held it in 6 quarters.
  • Iron Triangle Partners's Sanofi position peaked at $64.2M in Q1 2023.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Iron Triangle Partners's 13F filing for Q4 2024, filed 14 Feb 2025.